Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

RECRUITING

Weill Cornell Medicine NY-Presb, New York

RECRUITING

Memorial Sloan Kettering Cancer Ctr, New York

RECRUITING

Novartis Investigative Site, Marseille

RECRUITING

Novartis Investigative Site, Rozzano

RECRUITING

Sidney Kimmel CCC At JH, Baltimore

RECRUITING

Novartis Investigative Site, Lübeck

RECRUITING

Novartis Investigative Site, Brescia

RECRUITING

Novartis Investigative Site, Madrid

RECRUITING

Novartis Investigative Site, Madrid

RECRUITING

H Lee Moffitt Cancer Center and Research Institute, Tampa

RECRUITING

Vanderbilt University Medical Ctr, Nashville

RECRUITING

Novartis Investigative Site, Grenoble

RECRUITING

Novartis Investigative Site, Düsseldorf

WITHDRAWN

Novartis Investigative Site, Velbert

RECRUITING

Novartis Investigative Site, Nantes

RECRUITING

Mayo Clinic Rochester, Rochester

RECRUITING

Northwestern University, Chicago

RECRUITING

Novartis Investigative Site, Paris

RECRUITING

Univ of TX MD Anderson Cancer Cntr, Houston

RECRUITING

Huntsman Cancer Institute, Salt Lake City

RECRUITING

Stanford Cancer Center, Stanford

RECRUITING

Novartis Investigative Site, Singapore

WITHDRAWN

Novartis Investigative Site, Singapore

COMPLETED

Dana Farber Cancer Institute, Boston

RECRUITING

Novartis Investigative Site, Dresden

RECRUITING

Novartis Investigative Site, Leipzig

RECRUITING

Novartis Investigative Site, Hong Kong

RECRUITING

Novartis Investigative Site, Cardiff

RECRUITING

Novartis Investigative Site, London